title: Low density lipoprotein receptor-related protein 1 expression correlates with cholesteryl ester accumulation in the myocardium of ischemic cardiomyopathy patients.
abstract: Our hypothesis was that overexpression of certain lipoprotein receptors might be related to lipid accumulation in the human ischemic myocardium. Intramyocardial lipid overload contributes to contractile dysfunction and arrhythmias in cardiomyopathy. Thus, the purpose of this study was to assess the effect of hypercholesterolemic LDL and hypertrigliceridemic VLDL dose on LRP1 expression in cardiomyocytes, as well as the potential correlation between LRP1 expression and neutral lipid accumulation in the left ventricle tissue from ischemic cardiomyopathy patients. Cell culture experiments include control and LRP1-deficient cardiomyocytes exposed to lipoproteins under normoxic and hypoxic conditions. Explanted hearts from 18 ICM patients and eight non-diseased hearts (CNT) were included. Low density lipoprotein receptor-related protein 1 (LRP1), very low density lipoprotein receptor (VLDLR) and low density lipoprotein receptor (LDLR) expression was analyzed by real time PCR and Western blotting. Cholesteryl ester (CE), triglyceride (TG) and free cholesterol (FC) content was assess by thin layer chromatography following lipid extraction. Western blotting experiments showed that protein levels of LRP1, VLDLR and HIF-1α were significantly upregulated in ischemic hearts. Immunohistochemistry and confocal microscopy analysis showed that LRP1 and HIF-1α were upregulated in cardiomyocytes of ICM patients. In vitro studies showed that VLDL, LDL and hypoxia exerted an upregulatory effect on LRP1 expression and that LRP1 played a major role in cholesteryl ester accumulation from lipoproteins in cardiomyocytes. Myocardial CE accumulation strongly correlated with LRP1 levels in ischemic hearts. Taken together, our results suggest that LRP1 upregulation is key for myocardial cholesterol ester accumulation in ischemic human hearts and that LRP1 may be a target to prevent the deleterious effects of myocardial cholesterol accumulation in ischemic cardiomyopathy.
authors.affiliation: Cardiovascular Research Center, CSIC-ICCC, Hospital de Santa Creu I Sant Pau, Sant Antoni Ma Claret, 167, 08025, Barcelona, Spain.
authors.forename: Roi
authors.initials: R
authors.lastname: Cal
authors.forename: Oriol
authors.initials: O
authors.lastname: Juan-Babot
authors.forename: Vicenç
authors.initials: V
authors.lastname: Brossa
authors.forename: Santiago
authors.initials: S
authors.lastname: Roura
authors.forename: Carolina
authors.initials: C
authors.lastname: Gálvez-Montón
authors.forename: Manolo
authors.initials: M
authors.lastname: Portoles
authors.forename: Miguel
authors.initials: M
authors.lastname: Rivera
authors.forename: Juan
authors.initials: J
authors.lastname: Cinca
authors.forename: Lina
authors.initials: L
authors.lastname: Badimon
authors.forename: Vicenta
authors.initials: V
authors.lastname: Llorente-Cortés
mesh_terms: D000818:Animals; D015153:Blotting, Western; D002460:Cell Line; D002788:Cholesterol Esters / Q000378:metabolism*; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D007150:Immunohistochemistry; D026503:Low Density Lipoprotein Receptor-Related Protein-1 / Q000378:metabolism*; D008297:Male; D051379:Mice; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000378:metabolism*; D060888:Real-Time Polymerase Chain Reaction
chemical_list: D002788:Cholesterol Esters; D026503:Low Density Lipoprotein Receptor-Related Protein-1